CORBION NV (CRBN.AS) Stock Fundamental Analysis
Europe - AMS:CRBN - NL0010583399 - Common Stock
17.17 EUR
+0.13 (+0.76%)
Taking everything into account, CRBN scores 5 out of 10 in our fundamental rating. CRBN was compared to 66 industry peers in the Chemicals industry. CRBN has an average financial health and profitability rating. CRBN is cheap, but on the other hand it scores bad on growth. These ratings would make CRBN suitable for value investing!
1. Profitability
1.1 Basic Checks
CRBN had positive earnings in the past year.
In the past year CRBN had a positive cash flow from operations.
In the past 5 years CRBN has always been profitable.
Each year in the past 5 years CRBN had a positive operating cash flow.
1.2 Ratios
Looking at the Return On Assets, with a value of 4.55%, CRBN is in the better half of the industry, outperforming 74.24% of the companies in the same industry.
Looking at the Return On Equity, with a value of 9.12%, CRBN is in the better half of the industry, outperforming 69.70% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 9.19%, CRBN belongs to the top of the industry, outperforming 80.30% of the companies in the same industry.
CRBN had an Average Return On Invested Capital over the past 3 years of 6.62%. This is in line with the industry average of 6.62%.
The 3 year average ROIC (6.62%) for CRBN is below the current ROIC(9.19%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.55% | ||
| ROE | 9.12% | ||
| ROIC | 9.19% |
ROA(3y)7.34%
ROA(5y)6.93%
ROE(3y)16.91%
ROE(5y)15.8%
ROIC(3y)6.62%
ROIC(5y)7.13%
1.3 Margins
Looking at the Profit Margin, with a value of 5.11%, CRBN is in the better half of the industry, outperforming 68.18% of the companies in the same industry.
In the last couple of years the Profit Margin of CRBN has grown nicely.
CRBN has a Operating Margin of 8.68%. This is in the better half of the industry: CRBN outperforms 66.67% of its industry peers.
In the last couple of years the Operating Margin of CRBN has declined.
The Gross Margin of CRBN (26.10%) is worse than 62.12% of its industry peers.
In the last couple of years the Gross Margin of CRBN has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 8.68% | ||
| PM (TTM) | 5.11% | ||
| GM | 26.1% |
OM growth 3Y1.69%
OM growth 5Y-4.15%
PM growth 3Y26.84%
PM growth 5Y41.37%
GM growth 3Y-0.41%
GM growth 5Y-2.31%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CRBN is creating some value.
Compared to 1 year ago, CRBN has less shares outstanding
Compared to 5 years ago, CRBN has less shares outstanding
The debt/assets ratio for CRBN has been reduced compared to a year ago.
2.2 Solvency
CRBN has an Altman-Z score of 2.67. This is not the best score and indicates that CRBN is in the grey zone with still only limited risk for bankruptcy at the moment.
CRBN's Altman-Z score of 2.67 is fine compared to the rest of the industry. CRBN outperforms 66.67% of its industry peers.
CRBN has a debt to FCF ratio of 4.95. This is a neutral value as CRBN would need 4.95 years to pay back of all of its debts.
The Debt to FCF ratio of CRBN (4.95) is better than 78.79% of its industry peers.
CRBN has a Debt/Equity ratio of 0.39. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.39, CRBN is in the better half of the industry, outperforming 60.61% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.39 | ||
| Debt/FCF | 4.95 | ||
| Altman-Z | 2.67 |
ROIC/WACC1.41
WACC6.54%
2.3 Liquidity
A Current Ratio of 1.21 indicates that CRBN should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.21, CRBN is doing worse than 81.82% of the companies in the same industry.
A Quick Ratio of 0.60 indicates that CRBN may have some problems paying its short term obligations.
CRBN has a worse Quick ratio (0.60) than 89.39% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.21 | ||
| Quick Ratio | 0.6 |
3. Growth
3.1 Past
CRBN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -68.99%.
Measured over the past years, CRBN shows a very strong growth in Earnings Per Share. The EPS has been growing by 49.47% on average per year.
CRBN shows a small growth in Revenue. In the last year, the Revenue has grown by 2.95%.
CRBN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.70% yearly.
EPS 1Y (TTM)-68.99%
EPS 3Y34.95%
EPS 5Y49.47%
EPS Q2Q%-74.51%
Revenue 1Y (TTM)2.95%
Revenue growth 3Y6.35%
Revenue growth 5Y5.7%
Sales Q2Q%1.33%
3.2 Future
Based on estimates for the next years, CRBN will show a quite strong growth in Earnings Per Share. The EPS will grow by 13.30% on average per year.
Based on estimates for the next years, CRBN will show a decrease in Revenue. The Revenue will decrease by -0.24% on average per year.
EPS Next Y39.48%
EPS Next 2Y23.76%
EPS Next 3Y19.05%
EPS Next 5Y13.3%
Revenue Next Year-0.83%
Revenue Next 2Y1.12%
Revenue Next 3Y2.13%
Revenue Next 5Y-0.24%
3.3 Evolution
Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 15.33 indicates a correct valuation of CRBN.
Compared to the rest of the industry, the Price/Earnings ratio of CRBN indicates a somewhat cheap valuation: CRBN is cheaper than 75.76% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.41, CRBN is valued a bit cheaper.
CRBN is valuated reasonably with a Price/Forward Earnings ratio of 11.14.
Based on the Price/Forward Earnings ratio, CRBN is valued cheaply inside the industry as 84.85% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.88, CRBN is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.33 | ||
| Fwd PE | 11.14 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, CRBN is valued a bit cheaper than the industry average as 66.67% of the companies are valued more expensively.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CRBN indicates a rather cheap valuation: CRBN is cheaper than 92.42% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 10.02 | ||
| EV/EBITDA | 7.33 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of CRBN may justify a higher PE ratio.
CRBN's earnings are expected to grow with 19.05% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.39
PEG (5Y)0.31
EPS Next 2Y23.76%
EPS Next 3Y19.05%
5. Dividend
5.1 Amount
CRBN has a Yearly Dividend Yield of 3.72%. Purely for dividend investing, there may be better candidates out there.
CRBN's Dividend Yield is a higher than the industry average which is at 3.04.
CRBN's Dividend Yield is rather good when compared to the S&P500 average which is at 2.38.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.72% |
5.2 History
The dividend of CRBN has a limited annual growth rate of 5.02%.
Dividend Growth(5Y)5.02%
Div Incr Years1
Div Non Decr Years5
5.3 Sustainability
CRBN pays out 56.19% of its income as dividend. This is a bit on the high side, but may be sustainable.
The dividend of CRBN is growing, but earnings are growing more, so the dividend growth is sustainable.
DP56.19%
EPS Next 2Y23.76%
EPS Next 3Y19.05%
AMS:CRBN (9/19/2025, 9:22:15 AM)
17.17
+0.13 (+0.76%)
Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)
Earnings (Next)
Inst Owners75.76%
Inst Owner ChangeN/A
Ins Owners0.22%
Ins Owner ChangeN/A
Market Cap1.00B
Analysts77.14
Price Target23.38 (36.17%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.72% |
Yearly Dividend0.71
Dividend Growth(5Y)5.02%
DP56.19%
Div Incr Years1
Div Non Decr Years5
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-10.35%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-10.24%
EPS NY rev (3m)-10.24%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.53%
Revenue NY rev (3m)-2.44%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.33 | ||
| Fwd PE | 11.14 | ||
| P/S | 0.77 | ||
| P/FCF | 10.02 | ||
| P/OCF | 5.94 | ||
| P/B | 1.38 | ||
| P/tB | 1.58 | ||
| EV/EBITDA | 7.33 |
EPS(TTM)1.12
EY6.52%
EPS(NY)1.54
Fwd EY8.98%
FCF(TTM)1.71
FCFY9.98%
OCF(TTM)2.89
OCFY16.85%
SpS22.26
BVpS12.47
TBVpS10.88
PEG (NY)0.39
PEG (5Y)0.31
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.55% | ||
| ROE | 9.12% | ||
| ROCE | 10.92% | ||
| ROIC | 9.19% | ||
| ROICexc | 9.57% | ||
| ROICexgc | 10.55% | ||
| OM | 8.68% | ||
| PM (TTM) | 5.11% | ||
| GM | 26.1% | ||
| FCFM | 7.7% |
ROA(3y)7.34%
ROA(5y)6.93%
ROE(3y)16.91%
ROE(5y)15.8%
ROIC(3y)6.62%
ROIC(5y)7.13%
ROICexc(3y)7.16%
ROICexc(5y)7.83%
ROICexgc(3y)8.31%
ROICexgc(5y)9.44%
ROCE(3y)7.87%
ROCE(5y)8.47%
ROICexcg growth 3Y0.82%
ROICexcg growth 5Y-11.84%
ROICexc growth 3Y3.78%
ROICexc growth 5Y-8.06%
OM growth 3Y1.69%
OM growth 5Y-4.15%
PM growth 3Y26.84%
PM growth 5Y41.37%
GM growth 3Y-0.41%
GM growth 5Y-2.31%
F-Score6
Asset Turnover0.89
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.39 | ||
| Debt/FCF | 4.95 | ||
| Debt/EBITDA | 1.43 | ||
| Cap/Depr | 81.01% | ||
| Cap/Sales | 5.3% | ||
| Interest Coverage | 7.03 | ||
| Cash Conversion | 85.4% | ||
| Profit Quality | 150.76% | ||
| Current Ratio | 1.21 | ||
| Quick Ratio | 0.6 | ||
| Altman-Z | 2.67 |
F-Score6
WACC6.54%
ROIC/WACC1.41
Cap/Depr(3y)194.04%
Cap/Depr(5y)192.31%
Cap/Sales(3y)11.51%
Cap/Sales(5y)11.48%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-68.99%
EPS 3Y34.95%
EPS 5Y49.47%
EPS Q2Q%-74.51%
EPS Next Y39.48%
EPS Next 2Y23.76%
EPS Next 3Y19.05%
EPS Next 5Y13.3%
Revenue 1Y (TTM)2.95%
Revenue growth 3Y6.35%
Revenue growth 5Y5.7%
Sales Q2Q%1.33%
Revenue Next Year-0.83%
Revenue Next 2Y1.12%
Revenue Next 3Y2.13%
Revenue Next 5Y-0.24%
EBIT growth 1Y54.53%
EBIT growth 3Y8.15%
EBIT growth 5Y1.31%
EBIT Next Year139.88%
EBIT Next 3Y39.25%
EBIT Next 5Y20.69%
FCF growth 1Y171.85%
FCF growth 3YN/A
FCF growth 5Y21.2%
OCF growth 1Y118.83%
OCF growth 3Y101.81%
OCF growth 5Y9.98%